Overview
"The plight of a patient waiting months, sometimes years, for an organ transplant is one of the most heart-wrenching predicaments confronting medicine today. But the current critical shortage of human donor organs has had one positive consequence: it has stimulated promising new research into the field of xenotransplantation--the transplantation of organs from one animal species to another. In Xeno: The Promise of Transplanting Animal Organs Into Humans, David Cooper and Robert Lanza explore what may become one of the greatest medical advances of the 21st century. As scientists genetically engineer animal organs to evade the problems of rejection, we can expect a tremendous increase in xenotransplantation. This book recounts the several historical attempts to transplant animal organs into humans, and draws attention to the immense potential and promise of this form of therapy. The problems which remain, and recent breakthroughs in overcoming rejection and in ""humanizing"" pig organs for transplantation, are fully discussed. The authors also provide a fascinating consideration of the social and ethical questions posed by such procedures. Which patients should be the first to be offered this new form of therapy? Will transplanted animal organs transfer infectious viruses to the human recipient, and will they then be passed on to the community at large? Can society afford the major increase in healthcare expenditure that will result from our ability to provide a limitless number of donor organs? With profound implications for human health and longevity in the next millennium, Xeno is essential reading for anyone interested in the future of medicine."
Full Product Details
Author: David K. C. Cooper (Professor, Professor, Massachusetts General Hospital, Harvard Medical School) ,
Robert P. Lanza (Senior Director of Tissue Engineering and Transplant Medicine, Senior Director of Tissue Engineering and Transplant Medicine, Advanced Cell Technology Inc., USA) ,
Robin Cook
Publisher: Oxford University Press Inc
Imprint: Oxford University Press Inc
Dimensions:
Width: 15.70cm
, Height: 3.10cm
, Length: 23.60cm
Weight: 0.544kg
ISBN: 9780195128338
ISBN 10: 0195128338
Pages: 304
Publication Date: 23 March 2000
Audience:
General/trade
,
General
Format: Hardback
Publisher's Status: Active
Availability: To order
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.
Reviews
A concise and thorough analysis. --Journal of American Medical Association<br> Xeno offers both scientific and lay readers a lively, cogent, and comprehensive account of the scientific and ethical issues surrounding the use of animal organs and tissues for human transplantation. --Nature Biotechnology<br> Whereas the 20th century gave us the ability to perform open heart surgery and organ transplantation, the 21st century will offer us the capability of transplanting animal organs and cells into humans. XENO provides a fascinating review of previous and current scientific and surgical efforts in this field, with excellent discussions of its ethical, legal, and financial implications. It is a readable and balanced book, and will intrigue and stimulate anyone interested in what medicine may be able to offer within the next few years. --Christian N. Barnard, M.D.<br>
A concise and thorough analysis. --Journal of American Medical Association Xeno offers both scientific and lay readers a lively, cogent, and comprehensive account of the scientific and ethical issues surrounding the use of animal organs and tissues for human transplantation. --Nature Biotechnology Whereas the 20th century gave us the ability to perform open heart surgery and organ transplantation, the 21st century will offer us the capability of transplanting animal organs and cells into humans. XENO provides a fascinating review of previous and current scientific and surgical efforts in this field, with excellent discussions of its ethical, legal, and financial implications. It is a readable and balanced book, and will intrigue and stimulate anyone interested in what medicine may be able to offer within the next few years. --Christian N. Barnard, M.D.
Author Information
David Cooper, MD, is an Immunologist at the Transplantation Biology Research Center, Massachusetts General Hospital, and an Associate Professor of Surgery at Harvard Medical School. Robert Lanza, MD, is Senior Director of Tissue Engineering and Transplant Medicine, Advanced Cell Technology, Inc.
